Use of the elevated plus maze in the search for novel anxiolytic agents.
about
Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxalBehavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient miceDelta opioid receptor ligands modulate anxiety-like behaviors in the ratPotential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonistPreclinical animal anxiety research - flaws and prejudices.Pten regulates neuronal arborization and social interaction in mice.Effects of a post-weaning cafeteria diet in young rats: metabolic syndrome, reduced activity and low anxiety-like behaviourAbsence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fearRemoving obstacles in neuroscience drug discovery: the future path for animal models.Investigating the Role of Serotonin in Methamphetamine Psychosis: Unaltered Behavioral Effects of Chronic Methamphetamine in 5-HT1A Knockout Mice.Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms.Loss of cyclin-dependent kinase 5 from parvalbumin interneurons leads to hyperinhibition, decreased anxiety, and memory impairmentAstrocyte IP3R2-dependent Ca(2+) signaling is not a major modulator of neuronal pathways governing behaviorLithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficitsTet1 is critical for neuronal activity-regulated gene expression and memory extinction.Myristic acid produces anxiolytic-like effects in Wistar rats in the elevated plus maze.Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity.Maternal separation in early life modifies anxious behavior and Fos and glucocorticoid receptor expression in limbic neurons after chronic stress in rats: effects of tianeptine.Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites.Lifelong caloric restriction increases working memory in mice.Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in ratsDNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease.Experimental psychiatric illness and drug abuse models: from human to animal, an overviewCocaine withdrawal-induced anxiety in females: impact of circulating estrogen and potential use of delta-opioid receptor agonists for treatment.Temporal dynamics of anxiety phenotypes in a dental pulp injury modelRepeated cannabinoid administration increases indices of noradrenergic activity in ratsHandling of adolescent rats improves learning and memory and decreases anxiety.The use of the elevated plus maze as an assay of anxiety-related behavior in rodentsInvolvement of 5-HT1A Receptors in the Anxiolytic-Like Effects of Quercitrin and Evidence of the Involvement of the Monoaminergic System.Impaired burrowing is the most prominent behavioral deficit of aging htau mice.A trans-dimensional approach to the behavioral aspects of depression.Anticonvulsant and anxiolytic activity of the peptide fraction isolated from the venom of the social wasp Polybia paulistaTraumatic brain injury - modeling neuropsychiatric symptoms in rodents.Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life eventsPioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice.The anxiolytic effects of valtrate in rats involves changes of corticosterone levelsBehavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue.Differential effects of two chronic diazepam treatment regimes on withdrawal anxiety and AMPA receptor characteristics.
P2860
Q24613178-BB53FC48-AA06-4E5F-A64B-B5B9789F4C16Q24650165-639964CA-B6AB-4497-AF59-48E4F656F0E0Q24670438-FF8A8B56-F4BB-4085-9287-D7D9763F0102Q24673932-F613547B-BBF0-4ACC-B9CA-8D628EE8D695Q26749038-6EF2AB07-D70F-4796-AB37-0E83C006B70DQ28512488-84ADECE5-3566-4051-9BD6-5195A7B884AAQ28538837-79B68057-ED1B-4819-A381-9FB386E8A93BQ28588180-428EE4FB-5424-407E-B215-F8FD671D8BBDQ28755229-5DC2AA48-93BE-43CF-A478-641C0C09CDBDQ30357167-B5998115-030B-483F-8B23-58A64F5ABC9FQ30387419-0E81AA60-B1D9-4F67-92CB-9908E302F864Q30405049-F43E95DA-A6E5-4FC0-9C38-7E1F066AE9D1Q30424562-C8B93091-7293-4950-BB8C-2565B2D07D03Q30427997-D2052D20-ADBF-4C2B-99EA-A1FEEF3436DCQ30469917-7981C439-5381-456C-A996-04667F5CB0C1Q30661863-33FA9342-8D27-4C78-9700-3196C3BB2BF2Q34307102-22762356-5C58-4EE9-B40B-F13EA10365FDQ34445920-59FFE3DF-BAEB-4C07-A566-3A55039CCFD3Q34623161-1B549AB8-2B8A-45D5-8D56-9B7EBF3AD1EAQ34673822-F5103C6E-F971-4554-AB34-1A32BB8D16F6Q34706201-B2ADF663-1AFF-4D8F-B3A8-AC22CA95067BQ34851023-7DCABBE5-BBD3-4F5F-B1CB-7D77D37F4862Q34870846-CD75943B-7B0D-4E75-8FE4-72EAC0ABC200Q35754215-38B5462E-BE97-40AC-9F1A-10140FD7DE6DQ35774481-D47A1453-F6A5-4EB1-AFD5-7647373844AEQ35793130-7C4EC13A-5B18-4640-BBE3-ED8928308AF3Q35803593-BAA4E11B-CF55-47E0-819D-82110C94D21FQ35928133-1E43DE12-3CDE-4C2D-8E61-F296C302FB1DQ36248616-44FD90FC-980B-4FD9-BCDA-2A5AADAF1079Q36759180-C40F8CB0-9B12-4EF0-BEFF-D9AF52ADFE68Q36958784-C605CCEB-2097-42D2-9979-D671191EA452Q37025330-770A2AEE-6225-4792-BD11-B283E2268A6EQ37080557-1D354953-2695-4F03-8074-B5358DD6FFB6Q37202450-AFBDFF28-383E-4543-B5AE-FA4AC29E0586Q37218200-A2CD115C-A50E-463C-A7B2-FE90F32FD685Q37364474-CB98F60B-B76E-4053-A5EB-94DCB58DF0E6Q37486869-60815D54-BEE0-4490-93C7-2D4D94A8E8B5Q37690685-9DF5C428-FCC0-428E-A98F-80D660C2CD13Q37750487-BA7813F0-254C-48DE-BDEF-77880A92C58BQ38324632-B9321CEC-854C-42D2-A75C-2984B58FCA0F
P2860
Use of the elevated plus maze in the search for novel anxiolytic agents.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Use of the elevated plus maze in the search for novel anxiolytic agents.
@en
type
label
Use of the elevated plus maze in the search for novel anxiolytic agents.
@en
prefLabel
Use of the elevated plus maze in the search for novel anxiolytic agents.
@en
P1476
Use of the elevated plus maze in the search for novel anxiolytic agents.
@en
P2093
Tricklebank MD
P356
10.1016/S0165-6147(00)88973-7
P577
1995-02-01T00:00:00Z